Results of a phase II study involving copanlisib for relapsed indolent lymphoma.
Home / Resource Library / Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Results of a phase II study involving copanlisib for relapsed indolent lymphoma.